2291 — Lepu Scientech Medical Technology Shanghai Co Balance Sheet
0.000.00%
- HK$5.98bn
- HK$4.53bn
- CNY471.64m
- 67
- 40
- 36
- 45
Annual balance sheet for Lepu Scientech Medical Technology Shanghai Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | Interim Report | ARS |
| Standards: | IFRS | IFRS | IFRS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 18.8 | 713 | 1,203 | 1,267 | 1,125 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 46.2 | 25.6 | 31.5 | 34 | 72.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 106 | 793 | 1,329 | 1,416 | 1,417 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 68.4 | 94.2 | 97.5 | 109 | 121 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 333 | 1,120 | 1,810 | 1,987 | 2,083 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 77.6 | 730 | 63.5 | 59.2 | 84.4 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 78.9 | 734 | 65.1 | 60.2 | 86 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 254 | 385 | 1,745 | 1,927 | 1,997 |
| Total Liabilities & Shareholders' Equity | 333 | 1,120 | 1,810 | 1,987 | 2,083 |
| Total Common Shares Outstanding |